Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas

Overview of attention for article published in OncoTargets and therapy, February 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 1 news outlet
twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 29 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,409 followers.

RT @SarcomaAlliance: This technical abstract discusses trabectedin (Yondelis) for soft tissue sarcomas that are difficult to treat.... http…

Reply Repost Favourite

This technical abstract discusses trabectedin (Yondelis) for soft tissue sarcomas that are difficult to treat.... https://t.co/PV4ly47H3g

Reply Repost Favourite